2017
DOI: 10.1007/s11172-017-1864-y
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and antimycobacterial activity of N-isonicotinoyl-N′-alkylideneferrocenecarbohydrazides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…[10][11][12][13][14][15][16] On the other hand, ferrocene possessed high lipophilicity and had lower toxicity towards animals and humans. 17,18 Various synthetic approaches have been used to covalently link ferrocenes to other metals for achieving synergistic effects between the two metals. [19][20][21] This association of two active metals led to enhanced cytotoxicity in some cases.…”
Section: Introductionmentioning
confidence: 99%
“…[10][11][12][13][14][15][16] On the other hand, ferrocene possessed high lipophilicity and had lower toxicity towards animals and humans. 17,18 Various synthetic approaches have been used to covalently link ferrocenes to other metals for achieving synergistic effects between the two metals. [19][20][21] This association of two active metals led to enhanced cytotoxicity in some cases.…”
Section: Introductionmentioning
confidence: 99%
“…[1] During the first two decades of the 21st century, special attention was paid to the synthesis and bioassay of ferrocene derivatives carrying pharmacophoric groups, namely, nucleic bases, oligonucleotides, various heterocycles, amino acids, peptides, and sugars. [2][3][4][5][6][7][8] In vitro and in vivo studies have demonstrated that many of such modified ferrocenes display a wide spectrum of biological activities, including antianemic, [9] antimicrobial, [10] antibacterial, [11] antimalarial, [12] tuberculostatic, [13,14] and especially antitumor activities, see recent review articles. [15][16][17][18] Ferroceron (tetrahydrate of sodium salt of ortho-carboxybenzoyl ferrocene), which is the first and only currently ferrocene-based drug, has been effectively used for a long time for the treatment of iron deficiency pathologies.…”
Section: Introductionmentioning
confidence: 99%